{
    "code": "02020801",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020801",
    "time": "2016-11-18 19:55:05",
    "許可證字號": "衛署藥輸字第020801號",
    "註銷狀態": "已註銷",
    "註銷日期": "89\/03\/09",
    "註銷理由": "自請註銷",
    "有效日期": "89\/02\/11",
    "發證日期": "84\/02\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202080100",
    "中文品名": "樂賜平膠囊２５公絲",
    "英文品名": "LOXITANE CAPSULES 25MG",
    "適應症": "精神病狀態",
    "劑型": "130膠囊劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "LOXAPINESUCCINATE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1409901100  臺灣氰胺股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460108100  LEDERLE PHARMACEUTICAL DIVISION OF AMERICAN CYANAMID COMPANY",
        "製造廠廠址": "PEARL RIVER, NEW YORK 10965",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816800810",
            "成分名稱": "LOXAPINE SUCCINATE",
            "含量描述": "34.004",
            "含量": "34.0040000000",
            "單位": "MG"
        }
    ]
}